Abstract
This chapter focuses on two classic Krebs cycle disorders (2-oxoglutaric aciduria and fumarase deficiency) and two recently discovered disorders of the Krebs cycle, severely affecting mitochondrial function and mitochondrial maintenance (succinyl-CoA synthetase –SCS – deficiencies, characterized by mutations in SUCLA2 and SUCLG1 genes). Fumarase deficiency and 2-oxoglutaric aciduria are rare disorders with global developmental delay and severe neurologic problems in infants. Patients with oxoglutaric aciduria have a variable severity of neurological involvement and metabolic acidosis and develop severe microcephaly and mental retardation. A special form (DOOR syndrome) occurs with sensorineural deafness and osteodystrophy. Patients with fumarase deficiency present with either a fulminant course associated with fatal outcome within the first 2 years of life or a subacute encephalopathy with profound speech delay without metabolic crises. SUCLA2 and SUCLG1 defects have the clinical presentation of mitochondrial depletion syndromes with profound hypotonia, progressive dystonia, and muscular atrophy, in addition to severe sensorineural hearing impairment, which has been specifically associated with SUCLA2 defect. The most important clues for the diagnosis in all these disorders rely in urine organic analysis. 2-oxoglutaric aciduria leads to chronic metabolic acidosis and variable urinary excretion of 2-oxoglutarate, while fumarase deficiency occurs with an increased excretion of fumarate associated with succinate and lactate excretion with eventual 2-oxoglutaric aciduria. A normal excretion of fumaric acid and a relative high fumarase residual activity do not rule out fumarase deficiency. In questionable cases mutation analysis is needed to confirm the diagnosis. In SCS defects mild methylmalonic aciduria with abnormal urine carnitine-ester profile is associated with only subtle abnormalities of the Krebs cycle intermediates. Due to the recognizable pattern of dystonia/±deafness syndrome and mild methylmalonic aciduria in SCS defects, direct genetic testing is a possible approach in the diagnosis of SUCLA2 and SUCLG1 defects. Carrier screening in fumarase deficiency is important due to the possible increased risk for certain malignancies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allegri G, Fernandes MJ, Scalco FB et al (2010) Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis 33:411–419
Bonnefont JP, Chretien D, Rustin P et al (1992) Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr 121:255–258
Carrozzo R, Dionisi-Vici C, Steuerwald U et al (2007) SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130:862–874
Coughlin EM, Christensen E, Kunz PL et al (1998) Molecular analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab 63:254–262
De Meirleir L, Hansikova H, Zeman J et al (2006) Fumarate hydratase deficiency – a rare cause of development delay and seizures. J Inherit Metab Dis 29:106–108
Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142:104–112
Elpeleg O, Miller C, Hershkovitz E et al (2005) Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081–1086
Guffon N, Lopez-Mediavilla C, Dumoulin R et al (1993) 2-ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis 16:821–830
Johnson JD, Muhonen WW, Lambeth DO (1998) Characterization of the ATP- and GTP-specific succinyl-CoA synthetases in pigeon. The enzymes incorporate the same alpha-subunit. J Biol Chem 273:27573–27579
Kadrmas EF, Ray PD, Lambeth DO (1991) Apparent ATP-linked succinate thiokinase activity and its relation to nucleoside diphosphate kinase in mitochondrial matrix preparations from rabbit. Biochim Biophys Acta 1074:339–346
Kavanaugh-Black A, Connolly DM, Chugani SA, Chakrabarty AM (1994) Characterization of nucleoside-diphosphate kinase from Pseudomonas aeruginosa: complex formation with succinyl-CoA synthetase. Proc Natl Acad Sci U S A 91:5883–5887
Kohlschutter A, Behbehani A, Langenbeck U et al (1982) A familial progressive neurodegenerative disease with 2-oxoglutaric aciduria. Europ J Pediatr 138:32–37
Kowluru A, Tannous M, Chen HQ (2002) Localization and characterization of the mitochondrial isoform of the nucleoside diphosphate kinase in the pancreatic beta cell: evidence for its complexation with mitochondrial succinyl-CoA synthetase. Arch Biochem Biophys 398:160–169
Manning NJ, Olpin SE, Pollitt RJ et al (2000) Fumarate hydratase deficiency: increased fumaric acid in amniotic fluid of two affected pregnancies. J Inherit Metab Dis 23:757–759
Maradin M, Fumić K, Hansikova H et al (2006) Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations. J Inherit Metab Dis 29:683
Morava E, Steuerwald U, Carrozzo R et al (2009) Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. Mitochondrion. doi:10.1016/j.mito.2009.08.003
Ostergaard E, Hansen FJ, Sorensen N et al (2007a) Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 130:853–861
Ostergaard E, Christensen E, Kristensen E et al (2007b) Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81:383–387
Ostergaard E, Schwartz M, Batbayli M et al (2009) A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr. doi:10.1007/s00431-009-1007-z
Ottolenghi C, Hubert L, Allanore Y et al (2011) Clinical and biochemical heterogeneity associated with fumarase deficiency. Hum Mutat. doi:10.1002/humu.21534
Picaud S, Kavanagh KL, Yue WW et al (2011) Structural basis of fumarate hydratase deficiency. J Inherit Metab Dis 34:671–676
Rouzier C, Le Guédard-Méreuze S, Fragaki K et al (2010) The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein. J Med Genet 47(10):670–676. doi:10.1136/jmg.2009.073445
Surendran S, Michals-Matalon K, Krywawych S (2002) DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex. Am J Med Genet. 15;113(4):371–374
Tomlinson IP, Alam NA, Rowan AJ (2000) Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410
Trinh BC, Melhem ER, Barker PB (2001) Multi-slice proton MR spectroscopy and diffusion weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. Am J Neuroradiol 22:831–833
Zeman J, Krijt J, Stratilová L et al (2000) Abnormalities in succinylpurines in fumarase deficiency: possible role in pathogenesis of CNS impairment. J Inherit Metab Dis 23:371–374
Zinn AB, Kerr DS, Hoppel CL (1986) Fumarase deficiency: a new cause of mitochondrial encephalomyopathy. N Engl J Med 315:469–475
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Morava, E., Carrozzo, R. (2014). Disorders of the Krebs Cycle. In: Blau, N., Duran, M., Gibson, K., Dionisi Vici, C. (eds) Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40337-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-40337-8_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40336-1
Online ISBN: 978-3-642-40337-8
eBook Packages: MedicineMedicine (R0)